Market Cap 162.73B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.33
Forward PE 9.56
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 39,277,900
Avg Vol 41,664,922
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 95%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
StocktwitsNews
StocktwitsNews Sep. 3 at 4:51 AM
Why Did PFE, GTLB, COP Stocks Jump To 52-Week Highs Today? $PFE $GTLB $COP https://stocktwits.com/news/equity/markets/why-did-pfe-gtlb-cop-stocks-jump-to-52-week-highs-today/cZsMZSZRJHp
0 · Reply
jrh34
jrh34 Sep. 3 at 3:20 AM
$PFE is back in vogue. Makes $45-50 range achievable this year. I like the upside potential, especially with the rotation out of tech in Pharma.
1 · Reply
Agent8
Agent8 Sep. 3 at 2:43 AM
$PFE “The study tests PF-08103402, an oral drug given as a suspension or tablet, used once daily in most parts of the trial. It aims to manage asthma better by tracking how the drug moves through the body and interacts with food and other medicines, using placebo and a known drug, midazolam, as comparators in selected groups.” https://www.tipranks.com/news/company-announcements/pfizers-new-asthma-candidate-pf-08103402-enters-phase-1-what-investors-should-know#google_vignette LT
0 · Reply
TalkMarkets
TalkMarkets Sep. 2 at 11:26 PM
Did The #COVID Vaccine Ruin #Pfizer’s 6.1% Yield? $PFE https://talkmarkets.com/article/did-the-covid-vaccine-ruin-pfizers-61-yield-1788391565
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 10:24 PM
$PFE Price: $29.02 (+1.65%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 77.5 | Momentum: Moderate Volume: +3.3% vs avg Volatility: 1.44% Support: $25.30 | Resistance: $29.09 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:20 PM
$IBRX $MRNA $MRK $PFE $JNJ https://x.com/stkirsch/status/2094989788919267745?s=46
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:12 PM
$IBRX $MRNA.X $MRK $PFE $JNJ …alotta opinions on Makis, but WOW! https://x.com/makismedicine/status/2095156284513284405?s=46
1 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
1 · Reply
goguryo2000
goguryo2000 Sep. 2 at 8:07 PM
$PFE This is 3rd time it hit 29 and first time ended with 29 mark. 30 might come sooner than expected. Looking forward to see good old 35s and 36s.
1 · Reply
alexquick123
alexquick123 Sep. 2 at 7:47 PM
0 · Reply
Latest News on PFE
Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 2 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK


Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-24T12:18:00.000Z - 9 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue


Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 17 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN


Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 19 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 4 weeks ago

Pfizer Post Loss on Higher Revenue


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 1 month ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


StocktwitsNews
StocktwitsNews Sep. 3 at 4:51 AM
Why Did PFE, GTLB, COP Stocks Jump To 52-Week Highs Today? $PFE $GTLB $COP https://stocktwits.com/news/equity/markets/why-did-pfe-gtlb-cop-stocks-jump-to-52-week-highs-today/cZsMZSZRJHp
0 · Reply
jrh34
jrh34 Sep. 3 at 3:20 AM
$PFE is back in vogue. Makes $45-50 range achievable this year. I like the upside potential, especially with the rotation out of tech in Pharma.
1 · Reply
Agent8
Agent8 Sep. 3 at 2:43 AM
$PFE “The study tests PF-08103402, an oral drug given as a suspension or tablet, used once daily in most parts of the trial. It aims to manage asthma better by tracking how the drug moves through the body and interacts with food and other medicines, using placebo and a known drug, midazolam, as comparators in selected groups.” https://www.tipranks.com/news/company-announcements/pfizers-new-asthma-candidate-pf-08103402-enters-phase-1-what-investors-should-know#google_vignette LT
0 · Reply
TalkMarkets
TalkMarkets Sep. 2 at 11:26 PM
Did The #COVID Vaccine Ruin #Pfizer’s 6.1% Yield? $PFE https://talkmarkets.com/article/did-the-covid-vaccine-ruin-pfizers-61-yield-1788391565
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 10:24 PM
$PFE Price: $29.02 (+1.65%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 77.5 | Momentum: Moderate Volume: +3.3% vs avg Volatility: 1.44% Support: $25.30 | Resistance: $29.09 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:20 PM
$IBRX $MRNA $MRK $PFE $JNJ https://x.com/stkirsch/status/2094989788919267745?s=46
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:12 PM
$IBRX $MRNA.X $MRK $PFE $JNJ …alotta opinions on Makis, but WOW! https://x.com/makismedicine/status/2095156284513284405?s=46
1 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
1 · Reply
goguryo2000
goguryo2000 Sep. 2 at 8:07 PM
$PFE This is 3rd time it hit 29 and first time ended with 29 mark. 30 might come sooner than expected. Looking forward to see good old 35s and 36s.
1 · Reply
alexquick123
alexquick123 Sep. 2 at 7:47 PM
0 · Reply
Stockmaster198
Stockmaster198 Sep. 2 at 7:41 PM
$PFE it’s confirmed after market closed this will run past 100%
1 · Reply
Sb2001
Sb2001 Sep. 2 at 7:26 PM
$PFE sloooowly I step, inch by inch.
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 2 at 7:20 PM
$AZN $JNJ $MRK $PFE $SLS Shorts are pushing Dr. Stergiou to the brink and he might potentially release the GPS CURATIVE KRAKEN after the bell and wipe out cancer along with the shorts! ✌️🙏❤️‍🩹
0 · Reply
BB_88_
BB_88_ Sep. 2 at 7:14 PM
0 · Reply
WuTangClam
WuTangClam Sep. 2 at 6:58 PM
$PFE & $KHC $VZ .. dividend pick ups that were hard to miss with their monster dividends. Hopefully everybody was listening
0 · Reply
BWinner
BWinner Sep. 2 at 6:53 PM
$PFE $29!!!!!
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Sep. 2 at 6:50 PM
$PFE Really thought id sell the next time we got back here. But here I am deciding to stay. I have learned nothing and I am ready to get hurt again!
3 · Reply
jrh34
jrh34 Sep. 2 at 5:58 PM
$PFE Hot stock lately, let's see them get a deal on with $CRDF for Onvansertib in mCRC.
0 · Reply
zustrelaax
zustrelaax Sep. 2 at 5:56 PM
$PFE need catalyst to move 32 and next 36
0 · Reply
Fliptax
Fliptax Sep. 2 at 5:51 PM
$PFE $33-35 next stop
0 · Reply
jrh34
jrh34 Sep. 2 at 5:33 PM
$PFE is back in favor, which means $45-50 range is obtainable over the coming months.
0 · Reply
Willieberich
Willieberich Sep. 2 at 5:28 PM
$PFE break 29 on the close 30 is coming right away
0 · Reply